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Largest-Ever Cancer Prevention Study
to Examine the Effects of Selenium and
Vitamin E on Prostate Cancer Occurrence
by Vickie WIiiiams
and Michael Worley

n the largest study of
its kind ever conducted,
researchers are invesci�
gating the possibility that
two naturally occurring
substances found in common
foods might be able to prevent
prostate cancer. More than
32,000 men are being recruited
to participate in the Selenium
and Vitamin E Cancer Preven,
don Tlial ( ELECT) at more
than 400 study sites in the
United States, Canada, and
Puerto Rico, including The
University of Texas M. D.
Anderson Cancer Center.

In che Unacc<l races, pro race cancer
a� the �cconJ mo I common cancer an
men (after no nmclanoma skin cancer),
anJ the American Cancer Society
c,cimarc� chat 1c wall kill 30,200 men
in 2002. However, moM men with
pro:.ratc cancer will J,c of other cau�e:..
and tl 1:, ampo ,able to prcdic1 which

Gwen Corrigan, M.S.N., a nurse practitioner in che De rrmenc of Clinical Cancer
Pm'€Tluon, examines M. D. Anderson employee
while Patti Reed, R.N.,
abouc his parricipacion in che
a se111or research nurse in the cleparmiem, talk
elernum and V,mmin E Cancer Prevemion Trit1l ( ELECT).
prostate cancers will progress anJ which
will remain indolent and innocuous
throughout a man':, lifetime.
(Continued on next page)
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Trouble Spots: Early Detection Is Key

to the Successful Treatment of Melanoma
by Noelle Heinze

cattered across the skin,
signs of sun damage in
the form of freckles,
moles, wrinkles, and
lines mimic markings on a map,
depicting where we've been and
where we might go. Some skin
lesions will grow or change over
time and-without some type of
intervention-. -may eventually
become cancerous.

"Well, it's not a melanoma," said
Madeleine Duvic, M.D., chief of the
Section of Dermatology at The Univer
sity of Texas M. D. Anderson Cancer
Center, as she examined my mole to
demonstrate an investigational tool
called a Dermlite, which was built by
researchers at M. D. Anderson for use
in skin-imaging studies. The Dennlite
resembles a small hand-held magnifying
glass with a polarized light ring and,
unlike other dermatoscopes, is designed
to be used without applying oil to the
patient's skin. The technique is called
dermascopy, or epiluminescent micros
copy, and it helps physicians detect
small changes in skin moles.
The Dermlite reveals lines in
junctional nevi (flat moles) similar to
the veins in a leaf. A normal junctional
nevus has visible lines, indicating an
even distribution of melanocytes. A
change in this pattern is a sign of an
abnormal distribution of melanin-and
of a mole that should be biopsied for
histologic examination. Other tech,
niques, such as mole-mapping, which
involves taking high-resolution pictures
of moles, help to identify changes in
moles or new lesions that could be
melanomas.
Identifying moles that change may
be important in the early identification
of melanoma, the most deadly form of
skin cancer. Based on statistics from the
American Cancer Society, 53,600 new

Dr. Madeleine Ouvic, chief of the Section of Dermatology, uses a Dermlite to detect
minute changes in certain types of moles that could indicate melanoma. According to
Dr. Duvic, the incidence of melanoma has risen in recent years, but early detection of
the disease has al�o increased.

cases of melanoma will be diagnosed
and approximarely 7,400 people will die
from the disease chis year. "The inci
dence has gone up co about 1 in 90
people with a diagnosis of melanoma,
and they are getting it at younger ages;

however, it is being detected earlier
because of increased public awareness,"
said Dr. Duvic. "Melanomas are the
most likely skin cancers to metastasize
and to kUI a patient, and yet, if they
(Continued on
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